Editas Medicine reports Q4 loss of $0.06/share, narrower tha
Editas Medicine, Inc. (EDIT) reported a Q4 2025 loss of $0.06 per share, narrower by 72.1% compared to the consensus ...
Tuesday, June 23, 2026
Tag: Editas
-1024x683.jpg "Ending the Iran War to Stop an ‘Economic Catastrophe’")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.